These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 346366)

  • 1. A preliminary study on the behaviour and biochemical responses subsequent to the injection of 5,6-dihydroxytryptamine into the substantia nigra of the rat.
    Osborne NN; Neuhoff V; Sontag KH; Wolfarth S
    Experientia; 1978 Apr; 34(4):495-6. PubMed ID: 346366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra.
    Price MT; Fibiger HC
    Eur J Pharmacol; 1974 Dec; 29(2):249-52. PubMed ID: 4613562
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
    Giambalvo CT; Snodgrass SR
    Brain Res; 1978 Sep; 152(3):555-66. PubMed ID: 308384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intranigral administration of 6-hydroxydopamine and 5,7-dihydroxytryptamine on rat brain tryptamine.
    Juorio AV; Greenshaw AJ; Nguyen TV
    J Neurochem; 1987 May; 48(5):1346-50. PubMed ID: 3104539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unilateral 5,7-dihydroxytryptamine lesions of the dorsal raphe nucleus (DRN) and rat rotational behaviour.
    Blackburn TP; Foster GA; Heapy CG; Kemp JD
    Eur J Pharmacol; 1980 Oct; 67(4):427-38. PubMed ID: 7449825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphetamine response in rat after dopamine neurone destruction.
    Creese I; Iversen SD
    Nat New Biol; 1972 Aug; 238(86):247-8. PubMed ID: 4404010
    [No Abstract]   [Full Text] [Related]  

  • 7. Changed eating and locomotor behaviour in the rat after 6-hydroxydopamine lesions to the substantia nigra.
    Brook C; Iversen SD
    Neuropharmacology; 1975 Feb; 14(2):95-105. PubMed ID: 1171387
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of prolyl-leucyl-glycine amide on drug-induced rotation in lesioned rats.
    Smith JR; Morgan M
    Gen Pharmacol; 1982; 13(3):203-7. PubMed ID: 6124481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra.
    Robinson TE; Noordhoorn M; Chan EM; Mocsary Z; Camp DM; Whishaw IQ
    Synapse; 1994 May; 17(1):16-25. PubMed ID: 8042143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5,7-Dihydroxytryptamine lesions of the amygdala reduce amphetamine- and apomorphine-induced stereotyped behaviour in the rat.
    Carter CJ; Pycock CJ
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jul; 312(3):235-8. PubMed ID: 7190651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of 5,7-dihydroxytryptamine lesions of extrapyramidal and mesolimbic sites on spontaneous motor behaviour, and amphetamine-induced stereotypy.
    Carter CJ; Pycock CJ
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Jul; 308(1):51-4. PubMed ID: 573866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of p-chloroamphetamine and 5,7-dihydroxytryptamine on rotation and dopamine turnover.
    Giambalvo CT; Snodgrass SR
    Brain Res; 1978 Jun; 149(2):453-67. PubMed ID: 566608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine.
    Roger LJ; Breese GR; Morell P
    Brain Res; 1980 Sep; 197(1):95-112. PubMed ID: 6156743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences.
    Ahmad M; Saleem S; Ahmad AS; Yousuf S; Ansari MA; Khan MB; Ishrat T; Chaturvedi RK; Agrawal AK; Islam F
    J Neurochem; 2005 Apr; 93(1):94-104. PubMed ID: 15773909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The substantia nigra and stereotyped behaviour.
    Costall B; Naylor RJ; Olley JE
    Eur J Pharmacol; 1972 Apr; 18(1):95-106. PubMed ID: 4555563
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancement of apomorphine-induced rotational behaviour in rats following the combination of 6-hydroxydopamine and electrolytic lesions in the substantia nigra.
    Watanabe H; Watanabe K
    Jpn J Pharmacol; 1979 Feb; 29(1):93-104. PubMed ID: 459160
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of nigral projections to the thalamus in drug-induced circling behaviour in the rat.
    Reavill C; Jenner P; Leigh N; Marsden CD
    Life Sci; 1981 Mar; 28(13):1457-66. PubMed ID: 7017327
    [No Abstract]   [Full Text] [Related]  

  • 18. Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. I. Unilateral lesions.
    Dunnett SB; Björklund A; Stenevi U; Iversen SD
    Brain Res; 1981 Jun; 215(1-2):147-61. PubMed ID: 7260584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous recovery from motor asymmetry in adult rats with 6-hydroxydopamine-induced partial lesions of the substantia nigra.
    Dravid A; Jaton AL; Enz A; Frei P
    Brain Res; 1984 Oct; 311(2):361-5. PubMed ID: 6149789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 5,7-dihydroxytryptamine and 6-hydroxydopamine on head-twitch response induced by serotonin, p-chloroamphetamine, and tryptamine in mice.
    Orikasa S; Sloley BD
    Psychopharmacology (Berl); 1988; 95(1):124-31. PubMed ID: 3133691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.